The most recent trading session ended with BellRing Brands (BRBR) standing at $71.32, reflecting a +0.89% shift from the previouse trading day's closing. This move outpaced the S&P 500's daily gain of 0.1%. On the other hand, the Dow registered a gain of 0.69%, and the technology-centric Nasdaq increased by 0.06%.
Shares of the nutritional supplements company have appreciated by 11.87% over the course of the past month, outperforming the Medical sector's loss of 1.44% and the S&P 500's gain of 4.37%.
Investors will be eagerly watching for the performance of BellRing Brands in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on November 18, 2024. The company is expected to report EPS of $0.49, up 19.51% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $543.24 million, indicating a 14.95% increase compared to the same quarter of the previous year.
It is also important to note the recent changes to analyst estimates for BellRing Brands. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.45% higher. Right now, BellRing Brands possesses a Zacks Rank of #2 (Buy).
Investors should also note BellRing Brands's current valuation metrics, including its Forward P/E ratio of 34. This indicates a premium in contrast to its industry's Forward P/E of 24.96.
Also, we should mention that BRBR has a PEG ratio of 1.6. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. As of the close of trade yesterday, the Medical - Products industry held an average PEG ratio of 1.99.
The Medical - Products industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 74, which puts it in the top 30% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BellRing Brands Inc. (BRBR) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.